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Abstract
Available serological diagnostics do not allow the confirmation of clinically suspected leptospirosis at the early acute phase
of illness. Several conventional and real-time PCRs for the early diagnosis of leptospirosis have been described but these
have been incompletely evaluated. We developed a SYBR Green-based real-time PCR targeting secY and validated it
according to international guidelines. To determine the analytical specificity, DNA from 56 Leptospira strains belonging to
pathogenic, non-pathogenic and intermediate Leptospira spp. as well as 46 other micro-organisms was included in this
study. All the pathogenic Leptospira gave a positive reaction. We found no cross-reaction with saprophytic Leptospira and
other micro-organisms, implying a high analytical specificity. The analytical sensitivity of the PCR was one copy per reaction
from cultured homologous strain M 20 and 1.2 and 1.5 copy for heterologous strains 1342 K and Sarmin, respectively. In
spiked serum & blood and kidney tissue the sensitivity was 10 and 20 copies for M 20, 15 and 30 copies for 1342 K and 30
and 50 copies for Sarmin. To determine the diagnostic sensitivity (DSe) and specificity (DSp), clinical blood samples from 26
laboratory-confirmed and 107 negative patients suspected of leptospirosis were enrolled as a prospective consecutive
cohort. Based on culture as the gold standard, we found a DSe and DSp of 100% and 93%, respectively. All eight PCR
positive samples that had a negative culture seroconverted later on, implying a higher actual DSp. When using culture and
serology as the gold standard, the DSe was lower (89%) while the DSp was higher (100%). DSe was 100% in samples
collected within the first – for treatment important - 4 days after onset of the illness. Reproducibility and repeatability of the
assay, determined by blind testing kidney samples from 20 confirmed positive and 20 negative rodents both appeared
100%. In conclusion we have described for the first time the development of a robust SYBR Green real-time PCR for the
detection of pathogenic Leptospira combined with a detailed assessment of its clinical accuracy, thus providing a method
for the early diagnosis of leptospirosis with a well-defined satisfactory performance.
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Introduction
Leptospirosis is a zoonotic disease caused by pathogenic
bacteria of the genus Leptospira, which are transmitted directly or
indirectly from animals to humans. Leptospirosis occurs worldwide
but is most common in tropical and subtropical areas with high
rainfall [1,2]. Globally, an estimated number of 500,000 severe
cases occur annually with case fatality rates ranging from 3% to
70%, depending on the clinical manifestations [2,3]. Although the
exact number of mild cases is unknown, it is probable that the
burden exceeds that of severe leptospirosis. Preliminary results
indicate that the present reported incidence of severe leptospirosis
may present a significant underestimation of the actual cases,
making leptospirosis potentially one of the major neglected
infectious diseases. This underestimation is in part due to the
non-characteristic manifestations of the disease; leptospirosis is
often confused with other diseases that are endemic and epidemic
in similar environmental and climatologic conditions such as
dengue, rickettsiosis, enteric fevers and malaria. Thus clinical
diagnosis alone is not adequate in most cases and laboratory
confirmation is essential.
It is important to note, that in contrast to many of the
resembling diseases (e.g. dengue), leptospirosis can easily be
treated with antibiotics. This is provided that the diagnosis is
confirmed before the 5th day after disease onset, when treatment
with antibiotics is most effective [2,4,5]. One of the most
important current diagnostic tests, the microscopic agglutination
test (MAT), which is often used as the gold standard, is based on
serology and can only confirm the disease at a later acute phase
because anti-Leptospira antibodies generally become detectable only
5 to 7 days after onset of illness. Thus to enable starting treatment
at the most effective time point, the availability of an accurate
diagnostic test that is reliable in the early acute phase of the
disease, is essential for the most optimal treatment.
The Polymerase Chain Reaction (PCR) technique, which can
detect the DNA of pathogenic leptospires present in the blood of
PLoS ONE | www.plosone.org 1 September 2009 | Volume 4 | Issue 9 | e7093the patient in the first 5 to 10 days, may be a promising tool for
such early laboratory diagnosis.
PCR-based diagnostics have been effectively developed for a
wide range of microbes. Due to its high sensitivity, specificity and
speed of amplification, the PCR has been shown to be extremely
useful for detecting and identifying organisms in instances where
existing culture techniques have failed or have been inadequate
[6,7]. In the last two decades, several conventional PCRs for the
diagnosis of leptospirosis have been described, using a variety of
target genes, including rrs [8], flab [9] and ompL1 [10]. One of
these PCRs used two primers pairs, i.e. primer pair G1/G2
amplifying DNA from all pathogenic Leptospira spp. except L.
kirschneri and L. kirschneri-specific primer pair B64I/B64II [11].
When combined with Southern blotting using specific probes, this
PCR was highly specific for pathogenic Leptospira and had a
detection threshold of about 10 bacteria when applied to a variety
of clinical samples [12], making it useful for diagnostic purposes
[13]. Primers G1 and G2 target the secY gene [14].
Recently, a number of real-time PCRs were introduced as a
rapid and sensitive tool for leptospires detection, reducing the risk
of false positive results by carry-over contamination. PCRs
targeting the ligA, B genes [15], rrs gene [16], gyrB gene [17], the
conserved hypothetical protein coding locus LA0322 in L.
interrogans serovar Lai [18] and lipL32 [19,20] are claimed to be
specific for pathogenic Leptospira and therefore appropriate for
diagnostic purposes. However, considering the low sequence drift
in rrs [21–22], it is questionable whether this gene presents an
optimal target to discriminate between pathogenic and saprophyt-
ic leptospires. Besides, it is not always clear whether the amplicons
are well suited for species or strain discrimination, either by
sequencing following conventional amplification or by determin-
ing characteristic melting temperatures (Tm).
The gene secY encoding preprotein translocase for Leptospira is
located within the S10-spc-a locus containing genes for ribosomal
proteins[14,23]. secY is a house keeping gene that consists of alternating
conserved and variable regions, making it suitable to deduce primers
that generate amplicons with sufficient sequence heterogeneity to
enable phylogenetic interpretation for Leptospira [23–26].
The primary aim of the study is to develop a real-time PCR that
specifically detects pathogenic Leptospira and to determine its
diagnostic accuracy, including parameters such as sensitivity,
specificity and reproducibility. Secondly, this PCR should generate
an amplicon with sequence variability suitable for phylogenic
assessment for molecular epidemiological purposes.
Results
Design of the real-time PCR
Optimal conditions for the real-time PCR were determined by
performing reactions under various conditions using 5.1 10
212 gDN A ,
equivalent to 1000 genome copies, from Leptospirastrain M20. Optimal
conditions are mentioned as PCR profile in the Material and Methods
section. The optimal amount of internal amplification control (IAC)
was estimated as 0.87 10
215 gp e rr e a c t i o nv o l u m e ,t h es e q u e n c e so f
the generated amplicons had a similar high phylogenic potential as
found before for G1/G2 generated amplicons (Fig. S1).
Analytical specificity and sensitivity of the assay
Primer set SecYIVF/SecYIV specifically amplified DNA from
pathogenic Leptospira (Table 1). Intermediate and doubtful species
gave a negative result, except for L. inadai, serovar Kaup, strain LT
64–68 that gave a positive PCR result and L. inadai, serovar
Lincang, strain L14 and L. meyeri, serovar Perameles, strain
Bandicoot 343 that gave ambiguous results. A BLAST search in
GenBank did not reveal disturbing sequence identities between the
primers and secY of other micro-organisms. Consistently, we found
no cross-reaction with DNA from 46 other micro-organisms,
implying a high analytical specificity of the test (Table 2).
The sequence of PCR primers was deduced from sequences of
strains belonging to the species L. interrogans. Because genetic
relatedness is used to differentiate Leptospira species, the primer
annealing efficiency and hence the amplification efficiency might
vary depending on the species from which the template DNA was
isolated. Therefore, in addition to the homologous strain M 20, we
determined the analytic sensitivities of the PCR with DNA from
heterologous strains 1342 K and Sarmin. As listed in Table S1, the
analytical sensitivity ranged from 1 to 50 copies depending on the
strain and the biological materials, spiked with Leptospira.
Robustness of the assay
The real-time PCR appeared to be highly robust. Varying
concentrations of primers and MgCl2 as well as changing the
annealing temperature, the incubation and the elongation time did
not markedly affect the number of cycles in which the reaction
becomes detectable (Ct) (data not shown).
Diagnostic sensitivity and specificity
Clinical serum and blood samples from 26 confirmed positive
(15 by culture and 11 by serology) and 107 negative patients were
enrolled in the study (Fig. S2). Since clinical signs and symptoms
were too varied to summarize, we used hospitalization and
reference to the Intensive Care Unit (ICU) as criteria for severity
of the diseases (Table S2). All patients were from The Netherlands;
approximately 50% of the infections were acquired abroad,
usually during vacation in South-East Asia. 92% of the patients
were hospitalized and 45.8% attended the ICU, implying that the
vast majority of patients were severely ill. The male: female ratio
was 96:4 (Table S2), which is a typical ratio for The Netherlands.
Based on culture as the gold standard, the real-time PCR had a
diagnostic sensitivity (DSe) and diagnostic specificity (DSp) of 100%
and 93%, respectively (Table 3). All 8 PCR positive samples that
had a negative culture seroconverted later on, implying a higher
actualDSp.Whenusing confirmationbycultureandserologyasthe
gold standard, the DSe was lower (89%) as expected while the DSp
was higher (100%). By grouping these PCR results on basis of the
day of sample collection, i.e. 1–4 days and 5–10 days after onset of
the disease, the DSe was 100% and 69%, respectively (Table 3).
Thissupports a muchhigher value of the test at the early acute stage
of the disease when bacterial loads are probably highest.
Reproducibility and repeatability of the assay
All 20 positive tissue samples gave positive results and all 20
negative tissue samples were negative in each of the distinctly
performed tests implying a perfect ‘analytical’ repeatability and
reproducibility of the assay. Triplicate execution of the PCR on
the clinical samples in fact provides an estimate of the practical
repeatability. In 87.0% (20/23) of the samples two or more of the
triplicates was positive and in 13% (3/23) one of the triplicates was
positive (Fig. S2), implying that the diagnostic repeatability might
be lower. This is probably due to low concentrations of leptospires
in samples taken later in the acute phase because 85.0% of the
scores of $2/3 triplicates were obtained in samples taken within
the first 5 days of illness (data not shown).
Discussion
Conventional diagnosis of leptospirosis mainly relies on
serological techniques. These methods reach only suitable levels
Leptospira Real-Time PCR
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No. Serovar Serogroup Strain Species Status Result Reference
1 Hardjo Sejroe Hardjoprajitno L. interrogans Pathogenic + Brenner et al., 1999
2 Hebdomadis Hebdomadis Hebdomadis L. interrogans Pathogenic + Brenner et al., 1999
3 Canicola Canicola Hond Utrecht IV L. interrogans Pathogenic + Brenner et al., 1999
4 Lai Icterohaemorrhagiae Lai L. interrogans Pathogenic + Brenner et al., 1999
5 Copenhageni Icterohaemorrhagiae M 20 L. interrogans Pathogenic + Brenner et al., 1999
6 Muenchen Australis Mu ¨nchen C 90 L. interrogans Pathogenic + Brenner et al., 1999
7 Pomona Pomona Pomona L. interrogans Pathogenic + Brenner et al., 1999
8 Pyrogenes Pyrogenes Salinem L. interrogans Pathogenic + Brenner et al., 1999
9 Icterohaemorrhagiae Icterohaemorrhagiae RGA L. interrogans Pathogenic + Brenner et al., 1999
10 Zhenkang Javanica L82 L. borgpetersenii Pathogenic + Brenner et al., 1999
11 Sejroe Sejroe M84 L. borgpetersenii Pathogenic + Brenner et al., 1999
12 Ballum Ballum Mus 127 L. borgpetersenii Pathogenic + Brenner et al., 1999
13 Kenya Ballum Nijenga L. borgpetersenii Pathogenic + Brenner et al., 1999
14 Tarassovi Tarassovi Perepelicin L. borgpetersenii Pathogenic + Brenner et al., 1999
15 Poi Javanica Poi L. borgpetersenii Pathogenic + Brenner et al., 1999
16 Hardjo-bovis Sejroe Sponselee L. borgpetersenii Pathogenic + Brenner et al., 1999
17 Bim Autumnalis 1051 L. kirschneri Pathogenic + Brenner et al., 1999
18 Mozdok Pomona 5621 L. kirschneri Pathogenic + Brenner et al., 1999
19 Cynopteri Cynopteri 3522 C L. kirschneri Pathogenic + Brenner et al., 1999
20 Grippotyphosa Grippotyphosa Moskva V L. kirschneri Pathogenic + Brenner et al., 1999
21 Ratnapura Grippotyphosa Wumalasena L. kirschneri Pathogenic + Brenner et al., 1999
22 Proechimys Pomona 1161 U L. noguchii Pathogenic + Brenner et al., 1999
23 Panama Panama CZ 214 K L. noguchii Pathogenic + Brenner et al., 1999
24 Louisiana Louisiana LSU 1945 L. noguchii Pathogenic + Brenner et al., 1999
25 Rushan Australis 507 L. noguchi Pathogenic + Brenner et al., 1999
26 Shermani Shermani 1342 K L. santarosai Pathogenic + Brenner et al., 1999
27 Gorgas Sejroe 1413 U L. santarosai Pathogenic + Brenner et al., 1999
28 Tropica Pomona CZ 299 L. santarosai Pathogenic + Brenner et al., 1999
29 Bananal Aa14 L. santarosai Pathogenic + Brenner et al., 1999
30 Guaricura Sejroe Bov.G L. santarosai Pathogenic + Brenner et al., 1999
31 Manzhuang Hebdomadis A23 L. alexanderi Pathogenic + Brenner et al., 1999
32 Mengla Javanica A85 L. alexanderi Pathogenic + Brenner et al., 1999
33 Unipertama Sejroe K2-1 L. weilii Pathogenic + Brenner et al., 1999
34 Langati Tarassovi M 39090 L. weilii Pathogenic + Brenner et al., 1999
35 Mengdeng Celledoni M6906 L. weilii Pathogenic + Brenner et al., 1999
36 Celledoni Celledoni Celledoni L. weilii Pathogenic + Brenner et al., 1999
37 Sarmin Sarmin Sarmin L. weilii Pathogenic + Brenner et al., 1999
38 Coxi Javanica Cox L. weilii Pathogenic + Brenner et al., 1999
39 Pingchang Ranarum 80-412 genomospecies 1 Pathogenic + Brenner et al., 1999
40 Sofia Javanica Sofia 874 L. meyeri Pathogenic + Brenner et al., 1999
41 Perameles Mini Bandicoot 343 L. meyeri Pathogenic + Brenner et al., 1999
42 Ranarum Ranarum ICF L. meyeri Pathogenic + Brenner et al., 1999
43 Lincang Manhao L14 L. inadai Intermediate + Brenner et al., 1999
44 Kaup Tarassovi LT 64-68 L. inadai Intermediate + Brenner et al., 1999
45 Shermani Aguaruna MW 4 L. inadai Intermediate 2 Brenner et al., 1999
46 Lyme Lyme 10 L. inadai Intermediate 2 Brenner et al., 1999
47 5399 L. broomii Intermediate 2 Levett et al., 2006
48 L 065 L. broomii Intermediate 2 Levett et al., 2006
49 Hurstbridge Hurstbridge BUT 6 L. fainei Intermediate 2 Perolat et al, 1998
50 Varillal Hurstbridge VAR010 L. licerasiae Intermediate 2 Matthias et al., 2008
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treatment may be less effective. Leptospires are present in the
blood during the first 5 to 10 days after onset of the disease. Direct
detection of them would provide an excellent means to give early
confirmation of clinical suspicion. Direct observation of leptospires
in blood samples by darkfield microscopy is notoriously unreliable
and not recommended [2]. Isolation of leptospires can take up to
months and does not contribute to early diagnosis. Detection of
leptospires through specific PCR amplification of its DNA has
been championed as a promising alternative for two decades.
Several conventional PCR tests for the specific detection of
leptospiral DNA from body fluids and tissues have been described
[8–11,27,28]. Unfortunately evaluation of the clinical applicability
has only been done for two of such PCRs on a limited scale
[13,29], leaving the value of the conventional PCR for the
laboratory diagnosis unclear. A further drawback of the conven-
tional PCR is that the technique is particularly prone to
contamination resulting to false positive outcomes [30]. It is not
always clear whether serologically or culture negative but PCR
positive samples reflect a higher sensitivity of the PCR or are due
to contamination [31].
Real-time PCR, either using molecular beacons or SYBR
Green technology has the advantage that it gives a result much
quicker than conventional PCR and is less prone to contamina-
tion. By now, several real-time PCRs have been developed for the
detection of leptospires [15,16,18,19] but solid evaluations are
lacking and therefore their usability remains uncertain. An
auspicious exception is the recently described evaluation of a
Taq-man real-time PCR [17]. This test showed an analytical
sensitivity of 10 homologous genome copies and when compared
with culture proven leptospirosis patients had a DSe and DSp of
100% and 93%, respectively.
Here we describe the development and evaluation of a real-time
PCR based on the SYBR Green technology targeting the secY
gene. The primer pair we selected showed high specificity for
detection of pathogenic leptospires, excluding all saprophytic
strains tested and the vast majority of intermediate ones. The lack
of amplification of DNA from most intermediate strains is not
unexpected because their Leptospira species form a separate
intermediate clade situated between pathogenic and saprophytic
species [23,32]. This signifies a difference in DNA composition
compared to pathogenic species apparently resulting in a too low
annealing capacity of the primers hampering the amplification. In
our opinion, this is of little relevance for the diagnostic potential of
the test. Infection of patients with intermediate leptospires is a
relatively rare event and their pathogenic status is as yet doubtful.
Even though some of the intermediate Leptospira spp. have been
described as clinical isolates, virulence cannot convincingly be
demonstrated [33,34]. No cross-reaction was found with other
micro-organisms, which is an important feature because secY is a
house-keeping gene that has been demonstrated in many
prokaryotic species.
A major advantage of using the secY gene is its great
phylogenetic potential [22,24,25]. We recently demonstrated that
a small 245 bp segment of secY, flanked by the primer pair G1/G2
[11], had a high phylogenic power almost equaling that of the
whole gene thus making it a feasible and interesting target for
speciation by less sophisticated laboratories [23]. We found that
the 201 bp fragment of the gene amplified in this real-time PCR
assay had a similar phylogenetic potential as the 245 bp G1/G2
restricted fragment, making this target an attractive alternative for
sequencing and phylogeny following amplification in a conven-
tional format (Fig. S1).
The real-time PCR was validated using the specific instructions
from OIE [35]. We found an analytical sensitivity of 1 to 50
copies, depending on the degree of homology between strains from
different species and the type of sample used for extracting
Leptospira DNA. Taking into account the DNA extraction and
PCR protocols used in this study, detection of 1 genome copy per
reaction equals a concentration of 100 leptospires per ml culture
medium. This implicates a detection range from 100 to 5000
leptospires per ml or tissue equivalent, provided that the DNA
extraction is efficient. Hence the high analytical sensitivity cannot
be translated in a high practical efficiency, due to the sample
processing step in which DNA is not concentrated. Our main
future focus is therefore on developing a more adequate extraction
procedure.
Notably DNA extracted from urine and kidney samples
contained inhibitors. Both sample types are not essential for early
diagnosis of leptospirosis but have value in other situations such as
post-mortem investigations. We addressed the residual inhibition
in two ways. For urine we introduced an extra washing step in the
extraction procedure as most optimal tactic. For kidney samples
preparing 1:10 dilutions of the extracted DNA appeared the best
approach. Both methods have the disadvantage of losing or
diluting target DNA but overall the approaches led to markedly
higher success rates. Inhibition is a real problem as this leads to
false-negative results. To provide a tool to check on inhibitory
effects in the PCR we introduced an IAC.
For early diagnosis, blood and serum are ideal samples. The
immune system of the human body clears the bacteria from the
blood after approximately 5–7 days after appearance of clinical
manifestations. From one hand, the real-time PCR had a DSe of
100% when performed within the first four days of illness, which
statistically represents a bias, as leptospires are still present at high
concentrations in the patients’ blood. On the other hand early
confirmation of leptospirosis is of utmost importance for initiating
adequate treatment. Therefore, from a clinical point of view, the
No. Serovar Serogroup Strain Species Status Result Reference
51 Semaranga Semaranga Veldrat Semarang 173 L. meyeri Non-pathogenic 2 Victoria et al., 2008
52 Holland Holland WaZ Holland genomospecies 3 Non-pathogenic 2 Brenner et al., 1999
53 Saopaulo Semaranga Sao Paulo genomospecies 5 Non-pathogenic 2 Brenner et al., 1999
54 Andamana Andamana CH11 L. biflexa Non-pathogenic 2 Brenner et al., 1999
55 Patoc Semaranga Patoc I L. biflexa Non-pathogenic 2 Brenner et al., 1999
56 Codice Codice CDC L. wolbachii Non-pathogenic 2 Brenner et al., 1999
doi:10.1371/journal.pone.0007093.t001
Table 1. Cont.
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clinical decision making.
It should be noted that the very promising results of clinical
evaluation in this study have been achieved with samples from
Dutch patients. Currently half of the infections are acquired in
The Netherlands where the serovars Copenhageni, Icterohaemor-
rhagiae and Grippotyphosa are dominant. This might induce a
bias of the performance of the test. For this reason, the last stages
of the OIE validation scheme include field studies at other
laboratories to assess clinical sensitivity and specificity under
different circumstances. We are currently aiming at the imple-
mentation and evaluation of the test in endemic areas with a
variety of causative serovars.
In this study, culture and serology were considered as gold
standard to estimate the clinical sensitivity and specificity in order
to measure eventual bias of the results of high bacterial loads in
culture and PCR positive samples alone. The overall sensitivity
and specificity in this study were estimated as 93% and 100%,
respectively. The assay showed complete reproducibility and
repeatability as well as high level of robustness since changing in
critical PCR parameters has no or slight influence on overall
results.
Testing kidney, lung and liver from two early deceased patients
as well as some rodent kidneys proved clearly the usefulness of the
real-time PCR as an effective tool for the detection of Leptospira in
the distinct tissues. This shows the applicability of real-time PCR
as a suitable diagnostic tool on post-mortem samples, overcoming
the failure to confirm leptospirosis of early deceased patients by
serology.
Materials and Methods
Ethics statement
Procedures for collecting patients’ data and use of clinical
specimens for laboratory service improvement falls under the
umbrella of the ‘National Coordination Infectious Disease
Control’ (Landelijke Coo ¨rdinatie Infectieziektebestrijding, LCI)
[36], ‘Centre for Infectious Disease Control’ (Centrum Infectie-
ziektebestrijding, Cib), which is a formal body of the Netherlands
Ministry of Health and resides in the National Institute for Public
Health and Environment (RIVM) in Bilthoven, The Netherlands
and thus were conducted in compliance with the regulation,
policies and principles of the Dutch Public Health Service Policy.
The procedure includes the processing of anonymous data from
patients upon receipt of a written informed consent.
Leptospira strains and others organisms
Fifty-six Leptospira strains belonging to pathogenic, non-patho-
genic and intermediate Leptospira spp. (Table 1) and 46 other
micro-organisms (Table 2) were included in this study. Leptospira
strains were from the collection of the WHO/FAO/OIE and
National Leptospirosis Reference Centre in Amsterdam, The
Netherlands. Other micro-organisms or their genomic DNA were
gifts from colleagues from the Department of Biomedical Research
and from other institutions.
DNA extractions
Leptospires were propagated at 30uC in EMJH liquid media as
described by Ellinghausen and McCullough [37] as modified by
Johnson and Harris [38].
The number of bacteria per ml was determined by counting in a
Helber bacteria chamber (Weber Scientific international, West
Sussex BN15 8TN England) according to the standard protocol.
All genomic DNA from leptospires and other micro-organisms in
Table 2. Other micro-organisms used in this study.
No. Species
1 Acinetobacter calcoaceticus
2 Bartonella henselae
3 Bacillus subtilis
4 Bifidobacterium longum
5 Bordetella bronchiceptica
6 Borrelia burgdorferi
7 Brucella melitensis
8 Burkholderia cepacia
9 Campylobacter jejuni
10 Candida albicans
11 Candida dublinensis
12 Candida glabrata
13 Candida krusei
14 Candida parapsilosis
15 Corynebacterium diphteriae
16 Corynebacterium xerosis
17 Enterobacter aerogenes
18 Enterococcus faecalis
19 Enterococcus faecium
20 Escherichia coli
21 Helicobacter pylori
22 Klebsiella pneumoniae
23 Lactobacillus plantarum
24 Legionella pneumophila
25 Leishmania donovani
26 Leptonema illini
27 Listeria monocytogenes
28 Mycobacterium africanum
29 Mycobacterium bovis
30 Mycobacterium leprae
31 Mycobacterium tuberculosis
32 Neisseria gonorrhoeae
33 Pasteurella multocida
34 Plasmodium falciparum
35 Proteus mirabilis
36 Pseudomonas aeruginosa
37 Rickettsia akari
38 Salmonella enterica
39 Staphylococcus aureus
40 Streptococcus pneumoniae
41 Streptococcus sanguis
42 Trypanosoma cruzi
43 Toxoplasma gondii
44 Treponema pallidum
45 Turneriella parva
46 Yersinia enterocolitica
doi:10.1371/journal.pone.0007093.t002
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purified and eluted in 0.1xTE buffer pH 8.0 by using the QIAamp
DNA extraction kit (Qiagen, GmbH, D-40724 Hilden, Germany).
This was done in accordance with the manufacturer’s instructions
with a slight modification for urine samples by adding one step of
washing with the ALT buffer and proteinase K and spinning down
the urine samples at 13000 rpm for two minutes instead of
8000 rpm. The quantity of Leptospira genomic DNA was estimated
by measuring absorbance of DNA using the Spectrophotometer
ND-1000 Nanodrop (3411 Silverside Rd, Bancroft Building,
Wilmington, DE 19810, USA) and by visual comparison with
Smart Ladder SF (Eurogentec S.A, Liege Science Park, 4102
Seraing, Belgium) after agarose gel electrophoresis. Leptospira
interrogans serovar Copenhageni, strain M 20 was used as the basic
strain for the development and initial evaluation of the real-time
PCR. Based on the published genome of Copenhageni, one
genome equivalent corresponds to 5.1 10
215 g DNA [39].
Clinical samples
In this study we tested blood and serum samples from a
consecutive cohort of 133 Dutch patients suspected of leptospiro-
sis. Blood and serum samples from patients, clinically suspected for
leptospirosis were submitted for confirmation to the WHO/FAO/
OIE and National Leptospirosis Laboratory in Amsterdam in the
period August 2005 till August 2008. This centre functions as the
diagnostic centre for leptospirosis in The Netherlands and is
accredited according to ISO 15189.
The following exclusion criteria have been applied (Fig. S2): (i)
Patients from whom we did not receive a first sample within the
first 10 days after onset of the disease; this was done because of the
need for laboratory confirmation at the early acute phase. (ii)
Patients from whom we received a first sample of ,850 ml; this
was done to guard the integrity of the standard procedure for
diagnosis. (iii) No written informed consent for anonymous use of
data available or expressed objections against the use of clinical
specimens for improving laboratory services. All samples were
investigated prospectively.
In addition, kidney, liver and lung tissue samples from two fatal,
confirmed leptospirosis cases in the cohort with severe pulmonary
haemorrhagic syndrome (SPHS) and Weil’s syndrome were
included in the study.
Reference standards: Diagnostic culturing and serology
According to standard procedures of the reference centre,
culturing was performed on first samples only. MAT and IgM
ELISA were done on all samples included in the study.
A positive culture provides evidence of infection. For isolation,
aliquots of 0.1 ml of serum or EDTA anticoagulated whole blood
were inoculated into 6 ml EMJH culture medium and in Fletcher
medium as described in text book literature [2]. Incubation was
done at 30uC and cultures were inspected by darkfield microscopy
for growth of leptospires at regular intervals up to 4 months.
The microscopic agglutination test (MAT), which is accepted as
the standard reference test in the serodiagnosis of leptospirosis, was
performed as per standard procedure [2,40]. Performance of the
IgM ELISA was as described [2,34] using cut-off values defined in
the diagnostic protocols in The Netherlands [36]. Seroconversion
or a 4-fold or greater titer raise on paired samples was considered
confirmative.
Index test: the real-time PCR
Evaluation. Optimization and evaluation of the real-time
PCR was done according to the protocol for validation of
diagnostic PCRs of the OIE [35], which include working in
separate clean rooms and the use of positive and negative controls.
Real-time PCR was executed without knowledge on the outcome
of the reference tests and vice versa. Tests were performed by
skilled staff of the reference centre. For this paper, the instructions
of Standards for the Reporting of Diagnostic accuracy testing
(STARD) were followed [41].
Design of primers. secY sequences from pathogenic,
intermediate and saprophytic Leptospira [23] were aligned to
select primers that anneal efficiently with target DNA from
pathogenic leptospires but not with that from intermediate en
saprophytic species.
Real-time PCR standard parameters were taken into account in
the design of the primers. The resulting primer set SecYIVF (59-
GCGATTCAGTTTAATCCTGC-39) and SecYIV (59-GAGT-
TAGAGCTCAAATCTA- AG-39) are homologous to the Lepto-
spira interrogans S10-spc-a locus (Genbank accession number
AF115283) and amplify a 202 bp fragment between the locus
positions 15744 and 15946. To determine their potential
annealing specificity, the primer sequences were analysed with
the BLAST search homology database [42].
Reaction conditions. Real-time PCRs were performed on
an iQ
TM5 Multicolour Real-Time PCR Detection System (Bio-
Rad Laboratories, 2000 Alfred Nobel Drive, Hercules, CA94547
US) using the DNA-binding dye technique (SYBR Green). Unless
otherwise stated the following reaction conditions were used:
Reactions were performed in a total volume of 25 ml consisting of
1x iQ
TM SYBR Green Supermix (Bio-Rad) of 2x stock reagent
containing 100 mM KCl, 40 mM Tris-HCI, pH 8.4, 0.4 mM of
each dNTP, 50 units/ml iTaq DNA polymerase, 6 mM MgCl2,
20 nM fluoresein and stabilizers. Forward and reverse primers
were added at a final concentration of 400 nM each. ICA was
added in 0.5 ml volumes and DNA samples in 10 ml volumes. 10 ml
sterile water was used instead of DNA template for negative
Table 3. The diagnostic sensitivity, specificity and confidence interval.*
Day of illness Reference Standard TP FP TN FN DSe (%) CI (%) DSp (%) CI (%)
up to 4 Culture 9 3 63 0 100 63–100 96 86–99
up to 4 Culture + Serology 12 0 63 0 100 70–100 100 93–100
5t o1 0 Culture 6 5 47 0 100 52–100 90 78–96
5t o1 0 Culture + Serology 11 0 46 5 69 41–88 100 90–100
1t o1 0 Culture 15 8 110 0 100 75–100 93 87–97
1t o1 0 Culture + Serology 23 0 107 3 89 69–97 100 96–100
*TP, true positive; FP, false positive; TN, true negative; FN, false negative.
doi:10.1371/journal.pone.0007093.t003
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followed by 40 cycles of amplification (95uC for 5 s, 54uC for 5 s,
72uC for 15 s). Subsequently, the reaction was stopped at 95uC for
2 minutes, cooled (20uC for 1 min) and melted (70–94uC with
plate readings set at 0.5uC). The cut-off was set at Ct 35 that, in
our hands, was the last cycle completely devoid of back-ground
noise. To determine the optimal concentration of the PCR
reagents and the optimal annealing temperature, different reagents
concentrations were tested in combination with a temperature
gradient and various incubation times. All experiments were
repeated at least twice. The duration of the final PCR cycles was
approximately 100 minutes including generation of the melting
curve. The resulting data were analyzed using the software
provided by the iQ5 system (Bio-Rad iQ
TM5 2.0 Standard Edition
Optical System Software, V2.0.148.060623).
Construction of internal control, IAC. In order to
determine the inhibition in the biological samples and to identify
false negative results an IAC was constructed according to
Abdulmawjood et, al. [43], using the sequence of the secY gene
of Treponema pallidum, strain Nichols (GenBank accession number
AE000520) as a template. We selected a gene segment which
yielded a longer amplicon size (249 bp) and higher Tm (86uC)
than the Leptospira target in the real-time PCR. Primer pair secyicF
59-GCGATTCAGTTTAATCCTGCCCGC- CTGGTACTTC-
CCGG-39 and secyicR 59-GAGTTAGAGCTCAAATCTAAGG-
CCACGCCCTCCCAACC-39, consisted of a 39 part homologous
to the T. pallidum sequence and a 59 sequence corresponding to the
primers SecYIVF and SecYIV, respectively. The IAC amplicon
was constructed by performing a conventional PCR as follows;
enzyme activation for 10 minutes at 95uC followed by 34 cycles of
denaturation for 30 seconds at 95uC, annealing for 30 seconds at
50uC and elongation for 30 seconds at 72uC and a final extension
step for 7 minutes at 72uC. The PCR product was purified using
MinElute PCR Purification Kit as per manufacturer’s
recommendation (Qiagen, Germany) and cloned into the vector
pGEM-T (BaseClear Group, Leiden, The Netherlands) according
to standard procedures. To identify the optimal concentration for
use of this IAC in the real-time PCR, 0.5 ml aliquots of serial 10-
fold dilutions of IAC ranging from undiluted till a 10
12 fold
dilution were tested in the presence of 1000 genome copies of
DNA from strain M 20 per reaction. The optimal IAC
concentration was established on the criterion that a reliable
IAC amplicon was always present in the Leptospira negative
samples while no or a faint IAC product was generated in Leptospira
positive samples.
Analytical specificity and sensitivity
To investigate whether the deduced primer set SecYIVF and
SecYIV specifically amplify DNA from pathogenic Leptospira,w e
tested 5.1 10
212 g DNA per reaction from each of 42 Leptospira
strains belonging to eight pathogenic species and from 14 strains of
nine intermediate and saprophytic species (Table 1) as well as 46
other clinical important micro-organism (Table 2).
To estimate the detection threshold of the PCR (analytical
sensitivity), a standard curve was constructed using 10-fold serial
dilutions DNA template of homologous strain M 20 and
heterologous strains 1342 K and Sarmin producing relatively
intermediate and weak amplification, respectively, under these
standardized conditions. For fine-tuning of the end-point dilution,
the last positive 10-fold dilutions still giving a product were
subjected to subsequent 2-fold serial dilutions, performed inde-
pendently by two different persons. According to the OIE
recommendation [35], we set the end-point at the dilution in
which the assay could not detect the target in at least 5% of the
replicates.
To assess the extent of potentially inhibiting effects of biological
materials such as serum, blood, urine and tissue on the analytical
sensitivity, 10-fold serial dilutions followed by 2-fold serial dilution
of biological materials spiked with strains M 20, 1342 K and
Sarmin were targeted by the assay.
Robustness
To explore the effect of changing critical PCR parameters,
PCRs were performed with annealing temperature ranging from
52.5uC to 55.1uC and annealing time of 10, 15 and 20 seconds. To
determine the influence of changing the concentration of MgCl2
and primers, these were tested in the ranges of 3.0–4.0 mM and
0.2–0.4 mM, respectively. All the experiments were done in
triplicate and repeated at least twice.
Repeatability and reproducibility
The degree of agreement between replicates within the same
run (repeatability) or between replicates tested by different persons
(reproducibility) was measured based on the OIE recommendation
[35]. We tested blinded kidney samples from 20 confirmed positive
and 20 negative rodents, starting from DNA extraction, by two
different persons in triplicate for at least two times.
Diagnostic sensitivity (DSe) and specificity (DSp)
In first instance, we used positive cultures to corroborate the
infection for estimating DSe and DSp [35]. To assess an eventual
bias of PCR positive results towards high bacterial loads in culture
positive samples, we additionally performed calculations of DSe
and DSp on basis of reference standard, i.e. positive culture and or
serology.
Real-time PCR was executed in triplicate. Samples with two or
more positive reactions were scored as PCR positive. For
confirmation, samples with a single positive reaction were repeated
in triplicate. Samples were included when at least one of the
triplicates was again positive (Fig. S2). Sensitivity, specificity and
confidence intervals were calculated according to standard
literature [44–46].
Phylogeny
DNA sequence clustal alignments were done using Vector NTI
10 software (Invitrogen).
Phylogenetic analysis was conducted using MEGA4 [47]. One
thousand bootstrap replications were used to provide confidence in
the nodes. The tree was constructed by the Neighbor-Joining
method using the Jukes-Cantor model [47].
Supporting Information
Figure S1 Circular phylogenetic trees elaborated using the
Neighbor-joining method. Phylogenetic tree deduced from
SecYIV-IVF (A) and G1-G2 (B) restricted sequences using 1000
bootstrapping replicates.
Found at: doi:10.1371/journal.pone.0007093.s001 (0.54 MB TIF)
Figure S2 Inclusion flow chart. Flow diagram showing inclusion
of index patients and outcomes of the reference and index tests.
Found at: doi:10.1371/journal.pone.0007093.s002 (0.46 MB TIF)
Table S1 Analytical sensitivities*. * Detection threshold; Num-
bers of copies detected in one reaction.
Found at: doi:10.1371/journal.pone.0007093.s003 (0.02 MB
DOC)
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intensive care unit; N, no; Y, yes; U, unknown; -, negative; +,
positive
Found at: doi:10.1371/journal.pone.0007093.s004 (0.05 MB
DOC)
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